AUA 2013 - Slide Lecture: Introducing a new option before chemotherapy for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

SAN DIEGO, CA USA (UroToday.com) - Presented by Paul R. Sieber, MD at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA

 

 

________________________________________________________________


seiber pPaul R. Sieber, MD received his undergraduate degree in biology from Purdue University, subsequently earning his medical degree from Indiana University. He completed his internship and residency at Penn State Milton S. Hershey Medical Center. His specialties include prostate and renal cancers as well as general urology and urologic surgery.

Dr. Sieber is in private practice in a 12-doctor group in Lancaster, PA and has been extensively involved in clinical research for more than 15 years. He serves as the medical director for research at Lancaster Urology and has been a principal investigator in more than 150 clinical trials. His research interests are centered on prostate cancer with a particular interest in bone metastasis and bone loss with prostate cancer. He has authored more than 40 peer-reviewed papers.

aua

View Full AUA 2013 Coverage

 

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe